Patients with chronic critical illness face profound nutrition challenges after the ICU. Targeted nutrition therapy plays a critical role in recovery, functional improvement, and long-term outcomes.
Feature
The concepts of metabolically healthy obesity and metabolically unhealthy normal weight challenge BMI-centered thinking, highlighting why metabolic health, behaviors, and bias-free care matter more than body size alone.
Traditional meal plans often fail neurodivergent clients. Flexible, sensory-aware frameworks can help autistic and ADHD individuals build sustainable, satisfying eating routines that honor autonomy and real-life needs.
Dietitians play a critical but often overlooked role in reentry programs, where nutrition education can support chronic disease management, food security, and health equity for formerly incarcerated individuals.
Time-restricted eating has gained attention in oncology nutrition, with emerging research suggesting potential benefits for cancer risk reduction and metabolic health—though evidence in active cancer care remains limited.
With the growing food as medicine movement, it’s important for dietitians to know the limits of nutrition and lifestyle interventions so they can support their patients and clients who may be dealing with bone loss or at risk for it.
Young adults are seeking ways to enhance focus, mental clarity, and mental stamina, yet nutrition is often overlooked as a key factor in cognitive performance. Dietitians can integrate brain-focused nutrition education to empower this population to make more informed dietary decisions in ways that align with their values.
Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In this article, Today’s Dietitian interviewed four trailblazing RDs who are at the forefront of shaping AI in nutrition care.
This continuing education course examines the impact of vitamin D on diabetes. Vitamin D and calcium homeostasis may play direct and indirect roles in the development of diabetes and vitamin D can affect numerous complications associated with this disease state.
The newest generation of antiobesity medications (AOMs)—GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), dual action GLP-1/GIP combinations, triple action injectables, and emerging injectable and oral medications—have changed the landscape for weight management, bringing weight loss success to many for whom weight maintenance had previously not been possible.